Rotating-shift work tied to prostate cancer risk

	Tweet

The results of a study published in the American Journal of Epidemiology suggest there is a significant association between rotating-shift work and prostate cancer.

“Shift workers are known to be a high-risk population for...some cancers,” such as breast cancer and colorectal cancer, Dr. Tatsuhiko Kubo, of the University of Occupational and Environmental Health, Kitakyushu, Japan, and colleagues write.

The researchers looked for a link between shift work and the incidence of prostate cancer among 14,052 male workers enrolled in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. A survey on lifestyle factors was conducted between 1988 and 1990. 

The subjects were asked what their most common work schedule was: day work, rotating-shift work or night work. Overall, 11,269 (80.2 percent) were day workers, 982 (7.0 percent) were night workers, and 1801 (12.8 percent) worked a rotating-shift.

Thirty-one cases of prostate cancer were reported over an average follow-up period of 8 years.

When the data were adjusted for the effect of age, the researchers noted a three-fold increase in the risk of prostate cancer among the rotating-shift workers. A slight increase was also observed among the night workers.

These results were not significantly altered by further adjusting the data to account for other possible risk factors including family history of cancer, body mass index, smoking, alcohol consumption, job type, physical activity at work, perceived stress, educational level and marital status.

Kubo’s team suggests that reduced secretion of the hormone melatonin may be involved, since it helps induce sleep and has anticancer effects.

Because this is the first time that shift work has been identified as a risk factor for prostate cancer, they add that the “association needs to be replicated and confirmed in other settings.”

SOURCE: American Journal of Epidemiology, September 2006.

RELATED STORIES:
Gene Fusion Discovery May Lead to Improved Prostate Cancer Test   Low-income men show more high-risk prostate tumors   Prostate cancer screening may not reduce mortality   Urine test improves prostate diagnosis   Carcinoma of the Prostate (CAP)   Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death   Study Looks at Celebrex and Lipitor to Treat Prostate Cancer   New Approach for Treating Recurrent Prostate Cancer on the Horizon   For men with prostate cancer, treatment information fails to address fears   Researchers Uncover How Prostate Cancer Cells Defy Death   Prostate cancer therapy not tied to bladder cancer   Soya products, beans and sunflower seeds reduce risk of contracting prostate cancer   Newly Discovered Gene Fusion May Lead to Improved Prostate Cancer Diagnosis   Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy   Don’t believe hype about robot prostatectomy: study   Prostate Cancer: Watchful Wait or Vaccinate?   Prostate cancer screening: More harm than good?   Biofeedback cuts urine leak after prostate surgery   New type of adult stem cells found in the prostate may be involved in prostate cancer development   Family counseling improves lives of patients and spouses coping with prostate cancer   Men Who Are Continually Active at Work May Have Decreased Prostate Cancer Risk   Soft drink consumption may increase risk of pancreatic cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]